Benjamin Q. Duong

703 total citations
16 papers, 343 citations indexed

About

Benjamin Q. Duong is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Genetics. According to data from OpenAlex, Benjamin Q. Duong has authored 16 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pediatrics, Perinatology and Child Health, 10 papers in Pharmacology and 4 papers in Genetics. Recurrent topics in Benjamin Q. Duong's work include Pharmacogenetics and Drug Metabolism (10 papers), Pharmaceutical studies and practices (9 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Benjamin Q. Duong is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Pharmaceutical studies and practices (9 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Benjamin Q. Duong collaborates with scholars based in United States. Benjamin Q. Duong's co-authors include Julie A. Johnson, Larisa H. Cavallari, D. Max Smith, Amanda R. Elsey, James R. Rocca, Robert W. Huigens, Shouguang Jin, Fang Bai, Kristin Weitzel and Yan Gong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Pharmacology & Therapeutics and Pediatric Research.

In The Last Decade

Benjamin Q. Duong

14 papers receiving 336 citations

Peers

Benjamin Q. Duong
William D. Fiske United States
G KEARNS United States
Matthew J. Zaya United States
Raymond Miller South Africa
Benjamin Q. Duong
Citations per year, relative to Benjamin Q. Duong Benjamin Q. Duong (= 1×) peers Ismael Lares‐Asseff

Countries citing papers authored by Benjamin Q. Duong

Since Specialization
Citations

This map shows the geographic impact of Benjamin Q. Duong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Q. Duong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Q. Duong more than expected).

Fields of papers citing papers by Benjamin Q. Duong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Q. Duong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Q. Duong. The network helps show where Benjamin Q. Duong may publish in the future.

Co-authorship network of co-authors of Benjamin Q. Duong

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Q. Duong. A scholar is included among the top collaborators of Benjamin Q. Duong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Q. Duong. Benjamin Q. Duong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Duong, Benjamin Q., Nathan D. Seligson, Pamela Arn, et al.. (2025). Preferences for implementing pharmacogenomics in pediatric primary care: a discrete choice experiment. Pediatric Research. 98(6). 2211–2219.
2.
Seligson, Nathan D., Benjamin Q. Duong, Vicky L. Funanage, et al.. (2025). From bench to bedside: a spotlight on pharmacogenomics at Nemours Children’s Health. Pharmacogenomics. 26(7-9). 223–229.
3.
Seligson, Nathan D., et al.. (2025). Opportunities for Pharmacogenomics in Pediatrics: Prescribing Trends of Psychiatric Medications With Pharmacogenomic Implications at a Multistate Pediatric Health System. The Journal of Pediatric Pharmacology and Therapeutics. 30(2). 245–249. 1 indexed citations
4.
Duong, Benjamin Q., et al.. (2024). T cell Immunoglobulin and Mucin Domain Containing Protein 3 (TIM-3) Inhibitors in Oncology Clinical Trials: A Review. SHILAP Revista de lepidopterología. 7(2). 89–96. 5 indexed citations
5.
Duong, Benjamin Q., E. Anders Kolb, Manisha Bansal, et al.. (2023). Comparison of variants in TPMT and NUDT15 between sequencing and genotyping methods in a multistate pediatric institution. Clinical and Translational Science. 16(8). 1352–1358. 3 indexed citations
6.
Duong, Benjamin Q.. (2021). Realities of Pharmacogenomic and Minimizing Misconceptions and Medication Misadventures. Delaware Journal of Public Health. 7(5). 12–15. 3 indexed citations
7.
Langaee, Taimour, Benjamin Q. Duong, Dalia López‐Colón, et al.. (2021). β1‐receptor polymorphisms and junctional ectopic tachycardia in children after cardiac surgery. Clinical and Translational Science. 15(3). 619–625. 3 indexed citations
8.
Duong, Benjamin Q., Nathan D. Seligson, Pamela Arn, et al.. (2021). Key Considerations for Selecting a Genomic Decision Support Platform for Implementing Pharmacogenomics. Clinical Pharmacology & Therapeutics. 110(3). 555–558. 8 indexed citations
9.
Duong, Benjamin Q., Meghan J. Arwood, J. Kevin Hicks, et al.. (2020). <p>Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network</p>. Pharmacogenomics and Personalized Medicine. Volume 13. 217–226. 11 indexed citations
10.
Arwood, Meghan J., Eric Dietrich, Benjamin Q. Duong, et al.. (2020). Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic. Journal of Clinical Medicine. 9(7). 2274–2274. 39 indexed citations
11.
Levy, Kenneth D., R. Ryanne Wu, Daisuke Goto, et al.. (2020). Translating pharmacogenetics from research to routine clinical practice – a survey of the IGNITE Network. SHILAP Revista de lepidopterología. 5(1). 3 indexed citations
12.
Cicali, Emily J., et al.. (2020). A Scoping Review of the Evidence Behind Cytochrome P450 2D6 Isoenzyme Inhibitor Classifications. Clinical Pharmacology & Therapeutics. 108(1). 116–125. 31 indexed citations
13.
Smith, D. Max, Kristin Weitzel, Amanda R. Elsey, et al.. (2019). CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial. Genetics in Medicine. 21(8). 1842–1850. 105 indexed citations
14.
Weitzel, Kristin, Benjamin Q. Duong, Meghan J. Arwood, et al.. (2019). A Stepwise Approach to Implementing Pharmacogenetic Testing in the Primary Care Setting. Pharmacogenomics. 20(15). 1103–1112. 28 indexed citations
15.
Weitzel, Kristin, D. Max Smith, Amanda R. Elsey, et al.. (2018). Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons Learned. Clinical and Translational Science. 11(2). 175–181. 30 indexed citations
16.
Bai, Fang, et al.. (2013). Phenazine antibiotic inspired discovery of potent bromophenazine antibacterial agents against Staphylococcus aureus and Staphylococcus epidermidis. Organic & Biomolecular Chemistry. 12(6). 881–886. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026